Pasireotide Extended-Release Injection and Phenylephrine and triprolidine
Determining the interaction of Pasireotide Extended-Release Injection and Phenylephrine and triprolidine and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: pasireotide
Brand name: Signifor, Signifor LAR
Synonyms: Pasireotide
Generic Name: phenylephrine / triprolidine
Brand name: Prohist LQ, Histex PE, Histex-PE
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Pasireotide Extended-Release Injection-Phenylephrine Complex
- Pasireotide Extended-Release Injection-Phenylephrine Eye Drops 10%
- Pasireotide Extended-Release Injection-Phenylephrine Eye Drops 2.5%
- Pasireotide Extended-Release Injection-Phenylephrine Hydrochloride
- Pasireotide Extended-Release Injection-Phenylephrine Hydrochloride Injection
- Pasireotide Extended-Release Injection-Phenylephrine Injection
- Phenylephrine and triprolidine-Pasireotide Injection
- Phenylephrine and triprolidine-Pasireotide Subcutaneous
- Phenylephrine and triprolidine-Patanase
- Phenylephrine and triprolidine-Patiromer
- Phenylephrine and triprolidine-Patiromer Sorbitex Calcium
- Phenylephrine and triprolidine-Pavacot